Holly D. Soares PhD

Holly Soares is Group Director CV, Fibrosis and Genetically Defined Diseases at Bristol-Myers Squibb. She leads Translational Biomarkers for Cardiovascular, Metabolic, Neurodegenerative and Fibrotic Disorders. Prior to that, Holly was Director Clinical Biomarkers Neuroscience and Pain at Bristol-Myers Squibb. Before joining BMS, Holly was associate with Pfizer Pharmaceuticals for ten years.